Hsp90 present on the cell surface has been explored as a marker to assist in breast cancer diagnosis and margin status through fluorescent imaging, though there are technical challenges to be overcome for point-of-care translation (Crowe et al., 2017; Wang et al., 2021). This evidence concerns the gene HSP90AB1 and breast cancer.